Thirty Madison Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
700
- Latest Deal Type
-
M&A
- (Announced)
- Latest Deal Amount
-
$500M
- Investors
-
40
Thirty Madison General Information
Description
Operator of a human-first healthcare company intended to support the unique needs of the community with personalized treatments and care. The company builds condition-specific brands that provide end-to-end care for hair loss, a cure for migraine, a treatment for allergies, and a facet for skin conditions, enabling patients to get specialized healthcare brands that create exceptional outcomes for all.
Contact Information
Website
www.thirtymadison.comCorporate Office
- 82 Nassau Street
- Suite 61392
- New York, NY 10038
- United States
Corporate Office
- 82 Nassau Street
- Suite 61392
- New York, NY 10038
- United States
Thirty Madison Timeline
Thirty Madison Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 12-Aug-2025 | $500M | Announced | Generating Revenue | ||
| 10. Later Stage VC (Series C) | 11-Feb-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 01-Feb-2024 | Completed | Generating Revenue | |||
| 8. Debt - General | 12-Jun-2023 | Completed | Generating Revenue | |||
| 7. Mezzanine | 30-Dec-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 02-Jun-2021 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 06-Mar-2020 | Completed | Generating Revenue | |||
| 4. Debt - General | 01-Jan-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 16-Oct-2018 | $15.2M | $23M | Completed | Generating Revenue | |
| 2. Early Stage VC | 14-Nov-2017 | $5M | $7.75M | Completed | Startup |
Thirty Madison Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B-3 | ||||||||
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A | ||||||||
| Seed 2 | 3,476,042 | $0.000010 | $0.11 | $1.37 | $1.37 | $1.37 | 6.43% | |
| Seed 1 | 4,305,276 | $0.000010 | $0.05 | $0.64 | $0.64 | $0.64 | 7.97% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Thirty Madison Comparisons
Industry
Financing
Details
Thirty Madison Competitors (5)
One of Thirty Madison’s 5 competitors is Omada, a Formerly VC-backed company based in Dallas, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Omada | Formerly VC-backed | Dallas, TX | ||||
| Pariser Dermatology Specialists | Corporation | Norfolk, VA | ||||
| Nurx | Formerly VC-backed | San Francisco, CA | ||||
| Ro | Venture Capital-Backed | New York, NY | ||||
| Teladoc Health | Formerly VC-backed | New York, NY |
Thirty Madison Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Thirty Madison Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Thirty Madison Investors (40)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CVS Health Ventures | Corporate Venture Capital | Minority | ||
| Tournon Ventures | Venture Capital | Minority | ||
| 137 Ventures | Venture Capital | Minority | ||
| Alpha Partners | Venture Capital | Minority | ||
| Atacama Ventures | Venture Capital | Minority |
Thirty Madison Investments & Acquisitions (3)
Thirty Madison’s most recent deal was a Merger/Acquisition with Pill Club. The deal was made on 20-Apr-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pill Club | 20-Apr-2024 | Merger/Acquisition | Other Healthcare Services | ||
| Hey Favor (Certain Pharmaceutical Assets) | 13-Jun-2023 | Corporate Asset Purchase | Specialty Retail | ||
| Nurx | 01-Feb-2022 | Merger/Acquisition | Other Healthcare Services |
Thirty Madison Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Nurx | San Francisco, CA | 2015 |
Thirty Madison FAQs
-
When was Thirty Madison founded?
Thirty Madison was founded in 2016.
-
Where is Thirty Madison headquartered?
Thirty Madison is headquartered in New York, NY.
-
What is the size of Thirty Madison?
Thirty Madison has 700 total employees.
-
What industry is Thirty Madison in?
Thirty Madison’s primary industry is Clinics/Outpatient Services.
-
Is Thirty Madison a private or public company?
Thirty Madison is a Private company.
-
What is the current valuation of Thirty Madison?
The current valuation of Thirty Madison is .
-
What is Thirty Madison’s current revenue?
The current revenue for Thirty Madison is .
-
How much funding has Thirty Madison raised over time?
Thirty Madison has raised $249M.
-
Who are Thirty Madison’s investors?
CVS Health Ventures, Tournon Ventures, 137 Ventures, Alpha Partners, and Atacama Ventures are 5 of 40 investors who have invested in Thirty Madison.
-
Who are Thirty Madison’s competitors?
Omada, Pariser Dermatology Specialists, Nurx, Ro, and Teladoc Health are competitors of Thirty Madison.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
